MaxCyte Inc - Company Profile
Powered by 
All the sales intelligence you need on MaxCyte Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how MaxCyte Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with MaxCyte Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on MaxCyte Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into MaxCyte Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Maher Issa Masoud
Chief Executive Officer; Director; President Executive BoardMr. Maher Issa Masoud has been the President, Chief Executive Officer, and Director of the company since January 2024. Prior to this, he served as the Executive Vice President, Head of Global Business Development, and Chief Counsel of the company. Previously, he served as the Director and Corporate Counsel at Human Genome Sciences.
Parmeet Ahuja
Chief Financial Officer Senior ManagementMr. Parmeet Ahuja has been the Chief Financial Officer of the company since March 2026. Prior, he was the Vice President of Investor Relations at Agilent Technologies.
Douglas Swirsky
Chief Financial Officer Senior ManagementDouglas Swirsky has served as our Chief Financial Officer since March 2023. Prior to this, he served as Chief Financial Officer and Treasurer at AavantiBio Inc. Previously, he served as the President, Chief Executive Officer and a director at Rexahn Pharmaceuticals, Inc.
Ali Soleymannezhad
Chief Commercial Officer Senior ManagementMr. Ali Soleymannezhad has been the Chief Commercial Officer of the company since September 2024. Prior to this, he served as the Executive Vice President of Bioprocessing of the company. Previously, he served as the Executive Vice President at Tosoh Bioscience.
Richard Douglas, Ph.D
Chairman Non Executive BoardMr Richard Douglas has been the Chairman of the company since 2021. Prior to this, he served as the Senior Vice President of Corporate Development of Genzyme Corporation. Previously, he served as an Adviser to RedSky PartnersCynthia Collins and Executive Director of Labyrinth Choir Inc.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer